Status:
COMPLETED
Alcohol Detoxification in Primary Care Treatment (ADEPT)
Lead Sponsor:
University of Bristol
Conditions:
Alcoholism
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
Once someone becomes dependent on alcohol (alcoholic), the risks of complications from alcohol withdrawal when they stop drinking grow. These can include a life-threatening fit or delirium tremens (se...
Detailed Description
Aims and objectives: To provide a framework for investigating the hypothesis that for those patients undergoing alcohol detox in primary care adding acamprosate to a reducing regimen of a benzodiazep...
Eligibility Criteria
Inclusion
- Anyone (18-65 years old) consulting their GP for whom a community based alcohol detox requiring medication is appropriate.
- Due to acamprosate's license for maintaining abstinence, nobody under the age of 18 and over 65 will be recruited.
Exclusion
- Unsuitable for home/community detox, e.g., with current or significant history of:
- delirium tremens or seizures
- current or history of high dose polydrug use
- significant medical or psychiatric ill health
- pregnant or breast feeding
- Wernicke's encephalopathy
Key Trial Info
Start Date :
November 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2010
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00855699
Start Date
November 1 2009
End Date
November 1 2010
Last Update
January 19 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Bristol, Bristol PCT.
Bristol, United Kingdom, BS6 6JL